Urinary Incontinence News and Research

RSS
Urinary incontinence (UI), or the unintentional loss of urine, is a problem for more than 13 million Americans—85 percent of them women. Although about half of the elderly have episodes of incontinence, bladder problems are not a natural consequence of aging, and they are not exclusively a problem of the elderly.

Incontinence has several causes. Women are most likely to develop incontinence either during pregnancy and childbirth, or after the hormonal changes of menopause, because of weakened pelvic muscles. Older men can become incontinent as the result of prostate surgery. Pelvic trauma, spinal cord damage, caffeine, or medications including cold or over-the-counter diet tablets also can cause episodes of incontinence.

But even though urinary incontinence can be improved in 8 out of 10 cases, fewer than half of those with bladder problems ever discuss the condition with their health care professional. The condition often goes untreated.
Important that menopause not  viewed as a disease

Important that menopause not viewed as a disease

Increased risk of urinary incontinence with hormone therapy

Increased risk of urinary incontinence with hormone therapy

Clinical trial planned for stem cell treatment for stress urinary incontinence

Clinical trial planned for stem cell treatment for stress urinary incontinence

FDA approves Enablex for the treatment of overactive bladder

FDA approves Enablex for the treatment of overactive bladder

Researchers are successfully treating incontinent women with the patient's own muscle-derived stem cells

Researchers are successfully treating incontinent women with the patient's own muscle-derived stem cells

Urinary incontinence and abdominal pain are key symptoms of ovarian cancer

Urinary incontinence and abdominal pain are key symptoms of ovarian cancer

Urinary incontinence is passed down from mother to daughter

Urinary incontinence is passed down from mother to daughter

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

Prostate cancer treatment leads to declines in sexual and urinary function

Prostate cancer treatment leads to declines in sexual and urinary function

European positive for Cymbalta and Xeristar

European positive for Cymbalta and Xeristar

Yentreve available in Europe for treatment of stress urinary incontinence

Yentreve available in Europe for treatment of stress urinary incontinence

Cymbalta approved for diabetic peripheral neuropathy pain

Cymbalta approved for diabetic peripheral neuropathy pain

Cymbalta, treatment for major depression hits the market

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression

Cymbalta, a new treatment for major depression

Pfizer drug effectively treats overactive bladder symptoms

Pfizer drug effectively treats overactive bladder symptoms

Evidence of pelvic floor nerve injury after routine vaginal birth

Evidence of pelvic floor nerve injury after routine vaginal birth

Approval of Cymbalta for treatment of major depressive disorder

Approval of Cymbalta for treatment of major depressive disorder

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

Men with low prostate specific antigen levels on screening tests can still have prostate cancer